536 related articles for article (PubMed ID: 33542372)
1. Treatment of cytomegalovirus anterior segment infection with intravitreal injection of ganciclovir in adjunction with or without oral valganciclovir: a long-term results.
Cheng YC; Kang EY; Hwang YS; Hsiao CH
Sci Rep; 2021 Feb; 11(1):3105. PubMed ID: 33542372
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal loading injection of ganciclovir with or without adjunctive oral valganciclovir for cytomegalovirus anterior uveitis.
Hwang YS; Lin KK; Lee JS; Chang SH; Chen KJ; Lai CC; Huang JC; Kuo YH; Hsiao CH
Graefes Arch Clin Exp Ophthalmol; 2010 Feb; 248(2):263-9. PubMed ID: 19784845
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus Anterior Uveitis: Clinical Characteristics and Long-term Outcomes in a French Series.
Touhami S; Qu L; Angi M; Bojanova M; Touitou V; Lehoang P; Rozenberg F; Bodaghi B
Am J Ophthalmol; 2018 Oct; 194():134-142. PubMed ID: 30055154
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of corneal transplantation for irreversible corneal decompensation secondary to corneal endotheliitis in Asian eyes.
Ang M; Sng CC; Chee SP; Tan DT; Mehta JS
Am J Ophthalmol; 2013 Aug; 156(2):260-266.e2. PubMed ID: 23622566
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus endotheliitis in Descemet's stripping endothelial keratoplasty.
Anshu A; Chee SP; Mehta JS; Tan DT
Ophthalmology; 2009 Apr; 116(4):624-30. PubMed ID: 19195708
[TBL] [Abstract][Full Text] [Related]
6. Treatment outcome and risk factors for visual loss in Cytomegalovirus endotheliitis.
Chee SP; Jap A
Graefes Arch Clin Exp Ophthalmol; 2012 Mar; 250(3):383-9. PubMed ID: 21892696
[TBL] [Abstract][Full Text] [Related]
7. Sequential treatment of cytomegalovirus infection or disease with a short course of intravenous ganciclovir followed by oral valganciclovir: efficacy, safety, and pharmacokinetics.
Caldés A; Gil-Vernet S; Armendariz Y; Colom H; Pou L; Niubó J; Lladó L; Torras J; Manito N; Rufí G; Grinyó JM
Transpl Infect Dis; 2010 Jun; 12(3):204-12. PubMed ID: 20002612
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus-positive corneal stromal edema with keratic precipitates after penetrating keratoplasty: a case-control study.
Chee SP; Jap A; Ling EC; Ti SE
Cornea; 2013 Aug; 32(8):1094-8. PubMed ID: 23538617
[TBL] [Abstract][Full Text] [Related]
9. Successful corneal autograft after clearance of anterior chamber cytomegalovirus with oral valganciclovir in a patient with multiple failed corneal allografts.
Lusthaus JA; Kim P; Steller AK; Naing Z; Scott GM; Rawlinson WD; Robinson LP; McCluskey PJ; Wechsler AW
Cornea; 2011 Sep; 30(9):1054-7. PubMed ID: 21673567
[TBL] [Abstract][Full Text] [Related]
10. Similar reduction of cytomegalovirus DNA load by oral valganciclovir and intravenous ganciclovir on pre-emptive therapy after renal and renal-pancreas transplantation.
Kalpoe JS; Schippers EF; Eling Y; Sijpkens YW; de Fijter JW; Kroes AC
Antivir Ther; 2005; 10(1):119-23. PubMed ID: 15751769
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus as a cause of anterior uveitis in immunocompetent patients.
van Boxtel LA; van der Lelij A; van der Meer J; Los LI
Ophthalmology; 2007 Jul; 114(7):1358-62. PubMed ID: 17296229
[TBL] [Abstract][Full Text] [Related]
12. Long-term oral therapy with valganciclovir in patients with Posner-Schlossman syndrome.
Sobolewska B; Deuter C; Doycheva D; Zierhut M
Graefes Arch Clin Exp Ophthalmol; 2014 Jan; 252(1):117-24. PubMed ID: 24287937
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Topical Ganciclovir and Corticosteroids Preserve Corneal Endothelial Function in Cytomegalovirus Corneal Endotheliitis.
Fan NW; Chung YC; Liu YC; Liu CJ; Kuo YS; Lin PY
Cornea; 2016 May; 35(5):596-601. PubMed ID: 26967107
[TBL] [Abstract][Full Text] [Related]
14. Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients.
Johansson I; Mårtensson G; Nyström U; Nasic S; Andersson R
BMC Infect Dis; 2013 Dec; 13():582. PubMed ID: 24325216
[TBL] [Abstract][Full Text] [Related]
15. The validity of clinical feature profiles for cytomegaloviral anterior segment infection.
Hwang YS; Shen CR; Chang SH; Lai CC; Liu CL; Chen KJ; Lin KK; Chen TL; Hsiao CH
Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):103-10. PubMed ID: 20857136
[TBL] [Abstract][Full Text] [Related]
16. Treating HIV-associated cytomegalovirus retinitis with oral valganciclovir and intra-ocular ganciclovir by primary HIV clinicians in southern Myanmar: a retrospective analysis of routinely collected data.
Murray J; Hilbig A; Soe TT; Ei WLSS; Soe KP; Ciglenecki I
BMC Infect Dis; 2020 Nov; 20(1):842. PubMed ID: 33187478
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus as a cause of recurrent corneal endotheliitis in the Canadian population.
Bhamra J; Trask W; Lagrou L; Ford B; Kherani A; Wong J; Al-Ghoul A; Crichton A
Can J Ophthalmol; 2023 Oct; 58(5):417-421. PubMed ID: 35718025
[TBL] [Abstract][Full Text] [Related]
18. Retrospective review of the incidence of cytomegalovirus infection and disease after liver transplantation in pediatric patients: comparison of prophylactic oral ganciclovir and oral valganciclovir.
Bedel AN; Hemmelgarn TS; Kohli R
Liver Transpl; 2012 Mar; 18(3):347-54. PubMed ID: 22139888
[TBL] [Abstract][Full Text] [Related]
19. High efficacy and low toxicity of short-course oral valganciclovir as pre-emptive therapy for hematopoietic stem cell transplant cytomegalovirus infection.
Saleh AJ; Al Mohareb F; Al Rabiah F; Chaudhri N; Al Sharif F; Al Zahrani H; Mohamed SY; Patel M; Rasheed W; Nurgat Z; Bakr M; Ahmed S; Zaidi S; Nasser A; Ibrahim K; Al Abdely H; Aljurf M
Hematol Oncol Stem Cell Ther; 2010; 3(3):116-20. PubMed ID: 20890068
[TBL] [Abstract][Full Text] [Related]
20. Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients?
Jain A; Orloff M; Kashyap R; Lansing K; Betts R; Mohanka R; Menegus M; Ryan C; Bozorgzadeh A
Transplant Proc; 2005 Sep; 37(7):3182-6. PubMed ID: 16213344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
